Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis
The COVID-19 pandemic has severely affected adolescents. Safe and effective vaccines are pivotal tools in controlling this pandemic. We reviewed the safety profile of the BNT162b2 COVID-19 vaccine in adolescents using mostly real-world data to assist decision-making. We used random-effects model met...
Zapisane w:
Główni autorzy: | Patrick D. M. C. Katoto (Autor), Amanda S. Brand (Autor), Liliane N. Byamungu (Autor), Jacques L. Tamuzi (Autor), Tamirirashe C. Mahwire (Autor), Marcel K. Kitenge (Autor), Charles S. Wiysonge (Autor), Glenda Gray (Autor) |
---|---|
Format: | Książka |
Wydane: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Hasła przedmiotowe: | |
Dostęp online: | Connect to this object online. |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis
od: Patrick DMC. Katoto, i wsp.
Wydane: (2023) -
Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses
od: Patrick DMC Katoto, i wsp.
Wydane: (2023) -
Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
od: Yohhei Hamada
Wydane: (2021) -
Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer-BioNTech) COVID‐19 vaccination
od: Akihiro Matsubara, i wsp.
Wydane: (2021) -
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
od: Rumiko Shimazawa, i wsp.
Wydane: (2021)